Prognostic significance of new onset ascites in patients with pancreatic cancer

World Journal of Surgical Oncology

Volumn 4, Issue , 2006, Pages

  Zervos, Emmanuel E ^a,c   Osborne, Dana ^a   Boe, Brian A ^a   Luzardo, German ^a   Goldin, Steven B ^a,b   Rosemurgy, Alexander S ^a  

^a TAMPA GENERAL HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASCITES; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DATA BASE; FEMALE; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; PANCREAS CANCER; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE PERIOD; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 33746425710     PISSN: 14777819     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-4-16     Document Type: Article

References (15)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 2003, 53:5-26.
2. Zervos EE, Rosemurgy AS, Al-Saif O, Durkin AJ: Surgical management of early-stage pancreatic cancer. Cancer Control 2004, 11:23-31.
3. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Buchler MW: Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001, 358:1576-1585.
4. Adam RA, Adam YG: Malignant ascites: past, present, and future. J Am Coll Surg 2004, 198:999-1011.
5. Coates G, Bush RS, Aspin N: A study of ascites using lymphoscintigraphy with 99m Tc-sulfur colloid. Radiology 1973, 107:577-583.
6. Martin JKJ, Goellner JR: Abdominal fluid cytology in patients with gastrointestinal malignant lesions. Mayo Clin Proc 1986, 61:467-471.
7. Runyon BA, Montano AA, Akriviadis EA, Antillon MR, Irving MA, McHutchison JG: The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites. Ann Intern Med 1992, 117:215-220.
8. Runyon BA, Hoefs JC, Morgan TR: Ascitic fluid analysis in malignancy-related ascites. Hepatology 1988, 8:1104-1109.
9. Parsons SL, Watson SA, Steele RJ: Malignant ascites. Br J Surg 1996, 83:6-14.
10. Sayag-Beaujard AC, Francois Y, Glehen O, Sadeghi-Looyeh B, Bienvenu J, Panteix G, Garbit F, Grandclement E, Banssillon V, Vignal J, Gilly FN: Treatment of peritoneal carcinomatosis in patients with digestive cancers with combination of intraperitoneal hyperthermia and mitomycin C. Bull Cancer 2004, 91:E113-32.
11. Trigui B, Barrier A, Flahault A, Huguier M: [Prognostic factors in advanced pancreatic cancer. Multivariate analysis of predictive survival score. University Surgery Association]. Ann Chir 2000, 125:625-630.
12. Schmidt J, Fraunhofer S, Fleisch M, Zirngibl H: Is peritoneal cytology a predictor of unresectability in pancreatic carcinoma? Hepatogastroenterology 2004, 51:1827-1831.
13. Makary MA, Warshaw AL, Centeno BA, Willet CG, Rattner DW, Fernandez-del Castillo C: Implications of peritoneal cytology for pancreatic cancer management. Arch Surg 1998, 133:361-365.
14. Fernandez-del Castillo CL, Warshaw AL: Pancreatic cancer. Laparoscopic staging and peritoneal cytology. Surg Oncol Clin N Am 1998, 7:135-142.
15. Fernandez-del Castillo C, Rattner DW, Warshaw AL: Further experience with laparoscopy and peritoneal cytology in the staging of pancreatic cancer. Br J Surg 1995, 82:1127-1129.